The potential role of incretin-based therapies for polycystic ovary syndrome: a narrative review of the current evidence.

Mohammed Altigani AbdallaHarshal DeshmukhStephen AtkinThozhukat Sathyapalan

Published in: Therapeutic advances in endocrinology and metabolism (2021)

GLP-1 RAs and DPP-4 inhibitors have a promising therapeutic role in PCOS; however, larger clinical trials are needed to establish the role of incretin-based therapies in the management of PCOS.

Keyphrases

polycystic ovary syndrome
clinical trial
insulin resistance
adipose tissue
randomized controlled trial
wild type
metabolic syndrome
open label